The Institute of Human Virology, Nigeria (IHVN) has said it is pioneering a research project to develop a vaccine targeting ...

Researchers at Fred Hutchinson Cancer Center, led by Dr. Julie McElrath, Director of the Vaccine and Infectious Disease Division, have found a new way to train our immune system to make antibodies ...

Namibia has made significant strides in stemming the spread of HIV and AIDS through education and prevention. However, for ...

The second of two pivotal studies of a six-monthly HIV prevention injection containing the antiretroviral drug lenacapavir ...

The study found that vaccination reduced mpox cases by 84% in this population, providing a significant level of protection ...

The 5th HIV Research for Prevention Conference (HIVR4P 2024) held in Lima, Peru, marked a significant milestone in the global ...

This year has seen a double dose of optimism in the field of HIV prevention. First, on 20 June 2024, came the results of the Purpose-1 trial in South Africa and Uganda.1 This randomised controlled ...

Failure to ensure that everyone has access to prevention options to protect oneself from HIV acquisition, has resulted in at ...

To develop ways to combat this virus, understanding its structure is ... A Two-Dose Schedule Could Make HIV Vaccines More Effective Sep. 20, 2024 — Researchers have shown that they can generate ...

7 October 2024 (Lima, Peru) – New data from the PURPOSE 2 study of twice-yearly lenacapavir for HIV prevention are among the scientific highlights at HIVR4P 2024, the 5th HIV Research for Prevention ...